Journal Information
Original Article
Full text access
Pre-proof, online 7 July 2025
The role of miR-320d in regulation of cigarette smoke-induced pro-inflammatory responses in COPD
Mirjam P. Roffel1,2,3, Corry-Anke Brandsma1,2, Alen Faiz2,5, Marnix R. Jonker1,2, Wim Timens1,2, Guy F. Joos3, Guy G. Brusselle3, Tania Maes3, Ken R. Bracke3, Maarten van den Berge2,4, Irene H. Heijink1,2,4,
Corresponding author
h.i.heijink@umcg.nl

Corresponding author: Department of Pathology and Medical Biology University of Groningen, University Medical Center Groningen, Hanzeplein 1, 9700 RB Groningen, The Netherlands
1 University of Groningen, University Medical Center Groningen, Department of Pathology and Medical Biology, Groningen, The Netherlands
2 University of Groningen, University Medical Center Groningen, Groningen Research Institute for Asthma and COPD, The Netherlands
3 Ghent University, Ghent University Hospital, Laboratory for Translational Research in Obstructive Pulmonary Diseases, Department of Respiratory Medicine, Ghent, Belgium
4 University of Groningen, University Medical Center Groningen, Department of Pulmonology, Groningen, The Netherlands
5 University of Technology Sydney, Faculty of Science, Respiratory Bioinformatics and Molecular Biology (RBMB), Sydney, Australia
Article information
Abstract

Introduction: The mechanisms driving abnormal pro-inflammatory responses to cigarette smoke in COPD remain unclear. MicroRNA (miR)-320d was previously shown to have anti-inflammatory effects, being upregulated by inhaled corticosteroids. Therefore, our objective was to study whether miR-320d suppresses smoke-induced airway epithelial pro-inflammatory responses and if this is compromised in COPD.

Methods: We investigated the anti-inflammatory mechanisms of miR-320d in cigarette smoke extract (CSE)-exposed primary bronchial epithelial cells (PBECs), comparing COPD and control cells using a miR-320d mimic. Additionally, we assessed whether miR-320d expression is altered with COPD and its severity, investigating lung tissue from two independent cohorts of non-COPD controls (non/current/ex-smokers) and COPD patients (current/ex-smokers) with mild/moderate and severe disease.

Results: MiR-320d overexpression attenuated baseline and CSE-induced pro-inflammatory CXCL8, IL-1α and GM-CSF secretion in non-COPD-derived PBECs. This effect was not observed for CXCL8 and IL-1α in COPD-derived PBECs. RNA-sequencing showed that miR-320d significantly regulates the expression of 137 genes in CSE-exposed epithelium, the upregulated genes being enriched in “interleukin-33-mediated signaling” and the downregulated genes in “response to cytokine” (including IRAK1) pathways. Higher miR-320d levels were associated with lower IRAK1 expression in control but not COPD-derived PBECs. Finally, miR-320d levels were lower in lung tissue of COPD patients vs non-smoking controls and in severe vs mild/moderate COPD patients.

Conclusions: miR-320d’s suppressive effect on bronchial epithelial pro-inflammatory responses cells may be compromised in COPD. Additionally, miR-320d expression in lung tissue was lower with COPD severity. Thus, lower miR-320d anti-inflammatory action may contribute to persisting inflammation in COPD.

Keywords:
microRNA
anti-inflammatory
COPD
airway epithelium
cytokines
cigarette smoke
Full text is only available in PDF
Archivos de Bronconeumología
Article options
Tools

Are you a health professional able to prescribe or dispense drugs?